Delivery Order SPE2DB22D1002-SPE2DB25FKXZ1
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,414.56 firm fixed-price delivery order is for the supply of COPAXONE 20 MG/ML syringes, a medication used for the treatment of multiple sclerosis. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.00 firm fixed price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.28 Firm Fixed Price delivery order is for COPAXONE 40 MG/ML SYRINGEML, a specialty medication, with a period of performance through November 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,523.13 firm fixed-price delivery order is for COPAXONE 40 MG/ML syringes, which are used to treat multiple sclerosis. The award has an ultimate completion date of November 30, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order valued at $4,580.53 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication, with a period of performance through January 9, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.00, is for the supply of 4566719549 units of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for the delivery of COPAXONE 40 MG/ML syringes to the U.S. Defense agency, the Medical Supply Chain division. The $2,030.40 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The contract has a completion date of May 7, 2024. Amerisourcebergen also holds two Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency (DLA) Troop Support Medical and the...
This federal contract award, valued at $2,441.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of COPAXONE 20 MG/ML SYRINGE, a pharmaceutical product, with a completion date of April 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of COPAXONE 40 MG/ML syringes. The $2,297.04 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award is not associated with a set-aside program and has an ultimate completion date of September 4, 2024. Amerisourcebergen is one of...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company. The $2,232.72 Firm Fixed Price Delivery Order is for the supply of Copaxone 40 mg/ml syringes, a prescription medication. The contract has an ultimate completion date of July 10, 2024 and is not set aside for any specific business category. Amerisourcebergen holds a much larger Indefinite Delivery Contract (IDC)...